SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+11.27%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$629M
AUM Growth
+$629M
(+9.7%)
Cap. Flow
-$333K
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
38.9%
Holding
144
New
36
Increased
32
Reduced
27
Closed
33
Top Buys
| 1 |
Gilead Sciences
GILD
|
$25.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$19.2M |
| 3 |
Amgen
AMGN
|
$18.5M |
| 4 |
BLUE
bluebird bio
BLUE
|
$11.4M |
| 5 |
GSK
GSK
|
$10.7M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$28.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$13.7M |
| 4 |
SHPG
Shire pic
SHPG
|
$11.8M |
| 5 |
Amicus Therapeutics
FOLD
|
$10.3M |
Sector Composition
| 1 | Healthcare | 83.93% |
| 2 | Technology | 7.06% |
| 3 | Industrials | 1.82% |
| 4 | Consumer Discretionary | 1.62% |
| 5 | Financials | 1.56% |
